H. L. Ormond & Company, LLC Novartis Ag Put Options Transaction History
H. L. Ormond & Company, LLC
- $62.4 Million
- Q3 2022
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NVS
# of Institutions
1,434Shares Held
138MCall Options Held
1.48MPut Options Held
1.55M-
Dodge & Cox San Francisco, CA12.2MShares$1.31 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.3 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$864 Million0.23% of portfolio
-
Morgan Stanley New York, NY7.42MShares$792 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.95MShares$635 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...